Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Galvanized by ex-Pfizer researchers, Lycera is pursuing allosteric inhibitors of the mitochondrial ATPase and a nuclear receptor in autoimmune and inflammatory diseases.